Opioid peptides in immune cells

Advances in Experimental Medicine and Biology

Volumn 521, Issue , 2003, Pages 51-68

  Smith, Eric M ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENDORPHIN; BETA LIPOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEFERENS; DELTA OPIATE RECEPTOR; DYNORPHIN; ENDORPHIN; ENKEPHALIN; GAMMA ENDORPHIN; INTERLEUKIN 1; INTERLEUKIN 6; KAPPA OPIATE RECEPTOR; KETAZOCINE; MESSENGER RNA; MONOCLONAL ANTIBODY; MORPHINE; MU OPIATE RECEPTOR; N ALLYLNORMETAZOCINE; NALOXONE; NEUROPEPTIDE; NOCICEPTIN; OPIATE; OPIATE ANTAGONIST; OPIATE PEPTIDE; PEPTIDE ANTIBODY; SIGMA OPIATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; B LYMPHOCYTE; BETA ADRENERGIC STIMULATION; CROHN DISEASE; DRUG EFFECT; HEART INFARCTION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MULTIPLE SCLEROSIS; NEUROENDOCRINE SYSTEM; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVIEW; RHEUMATIC DISEASE; SEPTIC SHOCK; T LYMPHOCYTE;

ANALGESICS, OPIOID; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; FORECASTING; GENE EXPRESSION REGULATION; HORMONES; HUMANS; INFLAMMATION; LEUKOCYTES; LYMPHOCYTES; NALOXONE; NARCOTIC ANTAGONISTS; NEUROIMMUNOMODULATION; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS; OPIOID PEPTIDES; PRO-OPIOMELANOCORTIN; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, OPIOID; SHOCK, SEPTIC;

EID: 0037734284     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (119)

1. Smith EM, Blalock JE. Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci U S A 1981; 78(12):7530-7534.
2. Simon EJ, Hiller JM. Opioid peptides and opioid receptors. In: Siegel GS, Agranoff BW, Albers RW, Molinoff PB, editors. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. New York: Raven Press, 1994:321-339.
3. Krieger DT. Brain peptides: what, where, and why? Science 1983; 222(4627):975-985.
4. Gaveriaux-Ruff C, Matthes HW, Peluso J et al. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc Natl Acad Sci USA 1998; 95(11):6326-6330.
5. Carr DJ, Rogers TJ, Weber RJ. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc Soc Exp Biol Med 1996; 213(3):248-257.
6. Wybran J, Appelboom T, Famaey JP et al. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 1979; 123(3):1068-1070.
7. Johnson HM, Smith EM, Torres BA et al. Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci USA 1982; 79(13):4171-4174.
8. Mathews PM, Froelich CJ, Sibbitt WL et al. Enhancement of natural cytotoxicity by beta-endorphin. J Immunol 1983; 130(4):1658-1662.
9. McCain HW, Lamster IB, Bozzone JM et al. Beta-endorphin modulates human immune activity via nonopiate receptor mechanisms. Life Sci 1982; 31(15):1619-1624.
10. Faith RE, Liang HJ, Murgo AJ et al. Neuroimmunomodulation with enkephalins: enhancement of human natural killer (NK) cell activity in vitro. Clin Immunol Immunopathol 1984; 31(3):412-418.
11. Kay N, Allen J, Morley JE. Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci 1984; 35(1):53-59.
12. Lewis JW, Shavit Y, Terman GW et al. Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B). Nat Immun Cell Growth Regul 1983; 3(1):43-50.
13. Lewis JW, Shavit Y, Terman GW et al. Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 1983; 4(5):635-638.
14. Shavit Y, Lewis JW, Terman GW et al. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 1984; 223(4632):188-190.
15. Shipp MA, Stefano GB, D'Adamio L et al. Down-regulation of enkephalin-mediated inflammatory response by CD10/neutral endopeptidase-24.11 ("enkephalinase"). Nature 1990; 347:394-396.
16. Freier DO, Fuchs BA. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther 1994; 270(3): 1127-1133.
17. Carr DJ, Mayo S, Gebhardt BM et al. Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J Neuroimmunol 1994; 53(1):53-63.
18. Fecho K, Dykstra LA, Lysle DT. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J Pharmacol Exp Ther 1993; 265(3):1079-1087.
19. Hall DM, Suo JL, Weber RJ. Opioid mediated effects on the immune system: sympathetic nervous system involvement. J Neuroimmunol 1998; 83(1-2):29-35.
20. Stefano GB, Salzet B, Rialas CM et al. Morphine- and anadamide-stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res Dev Brain Res 1997; 763(1):63-68.
21. Blalock JE, Smith EM. Human leukocyte interferon: structural and biological relatedness to adreno-corticotropic hormone and endorphins. Proc Natl Acad Sci USA 1980; 77(10):5972-5974.
22. Blalock JE, Smith EM. Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity. Biochem Biophys Res Commun 1981; 101(2):472-478.
23. Dafny N. Interferon as an endocoids candidate preventing and attenuating opiate addiction. In: Lal H, LaBella F, Lane J, eds. Endocoids. New York: Alan R. Liss, Inc., 1985:269-276.
24. Lolait SJ, Lim AT, Toh BH et al. Immunoreactive beta-endorphin in a subpopulation of mouse spleen macrophages. J Clin Invest 1984; 73(1):277-280.
25. Smith EM, Galin FS, LeBoeuf RD et al. Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of a truncated peptide. Proc Natl Acad Sci USA 1990; 87(3):1057-1060.
26. Westly HJ, Kleiss AJ, Kelley KW et al. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med 1986; 163(6):1589-1594.
27. Lolait SJ, Clements JA, Markwick AJ et al. Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest 1986; 77(6):1776-1779.
28. Bardin CW, Chen CL, Morris PL et al. Proopiomelanocortin-derived peptides in testis, ovary, and tissues of reproduction. Recent Prog Horm Res 1987; 43:1-28.
29. Lacaze-Masmonteil T, de Keyzer Y, Luton JP et al. Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc Natl Acad Sci USA 1987; 84(20):7261-7265.
30. Buzzetti R, McLoughlin L, Lavender PM et al. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 1989; 83(2):733-737.
31. Stephanou A, Fitzharris P, Knight RA et al. Characteristics and kinetics of proopiomelanocortin mRNA expression by human leucocytes. Brain Behav Immun 1991; 5(4):319-327.
32. Galin FS, LeBoeuf RD, Blalock JE. Corticotropin-releasing factor upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes. J Neuroimmunol 1991; 31(1):51-58.
33. Galin FS, LeBoeuf RD, Blalock JE. Possible alternate splicing or initiation of the pro-opiomelanocortin gene in lymphocytes. Int J Neurosci 1990; 51(3-4):171-172.
34. Mechanick JI, Levin N, Roberts JL et al. Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leukocytes. Endocrinology 1992; 131(1):518-525.
35. Maier CC, Blalock JE. PCR-based cloning, sequencing, and exon mapping of lymphocyte- derived neuroendocrine peptides. Immunomethods 1994; 5(1):3-7.
36. Olsen NJ, Nicholson WE, DeBold CR et al. Lymphocyte-derived adrenocorticotropin is insufficient to stimulate adrenal steroidogenesis in hypophysectomized rats. Endocrinology 1992; 130(4):2113-2119.
37. van Woudenberg AD, Metzelaar MJ, van der Kleij AA et al. Analysis of proopiomelanocortin (POMC) messenger ribonucleic acid and POMC-derived peptides in human peripheral blood mononuclear cells: no evidence for a lymphocyte-derived POMC system. Endocrinology 1993; 133(5):1922-1933.
38. Lyons PD, Blalock JE. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol 1997; 78(1-2):47-56.
39. Smith EM. Corticotropin and immunoregulation. In: Scharrer B, Smith EM, Stefano GB, eds. Neuropeptides and immunoregulation. Berlin: Springer-Verlag, 1994:28-45.
40. Oates EL, Allaway GP, Armstrong GR et al. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J Biol Chem 1988; 263(21):10041-10044.
41. Hashemi FB, Hughes TK, Smith EM. Human immunodeficiency virus induction of corticotropin in lymphoid cells. J Clin Endocrinol Metab 1998; 83(12):4373-4381.
42. Smith EM, Hughes TK, Jr., Hashemi F et al. Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1992; 89(2):782-786.
43. Traber DL, Thomson PD, Blalock JE et al. Action of an opiate receptor blocker on ovine cardiopulmonary responses to endotoxin. Am J Physiol 1983; 245(2):H189-93.
44. Harbour-McMenamin D, Smith EM, Blalock JE. Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect Immun 1985; 48(3):813-817.
45. Harbour-McMenamin D, Smith EM, Blalock JE. B lymphocyte enriched populations produce immunoreactive endorphin that binds to delta opiate receptors and may play a role in endotoxic shock. ICSU Short Report 1986; 4:378-379.
46. Clarke BL, Gebhardt BM, Blalock JE. Mitogen-stimulated lymphocytes release biologically active corticotropin. Endocrinology 1993; 132(3):983-988.
47. Lyons PD, Blalock JE. The kinetics of ACTH expression in rat leukocyte subpopulations. J Neuroimmunol 1995; 63(2):103-112.
48. Smith EM, Phan M, Kruger TE et al. Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci USA 1983; 80(19):6010-6013.
49. Smith EM, Meyer WJ, Blalock JE. Virus-induced corticosterone in hypophysectomized mice: a possible lymphoid adrenal axis. Science 1982; 218(4579):1311-1312.
50. Smith EM, Morrill AC, Meyer III WJ et al. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 1986; 322:881-882.
51. Kavelaars A, Ballieux RE, Heijnen CJ. The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. J Immunol 1989; 142(7):2338-2342.
52. Kavelaars A, Ballieux RE, Heijnen CJ. Beta-endorphin secretion by human peripheral blood mononuclear cells: regulation by glucocorticoids. Life Sci 1990; 46(17):1233-1240.
53. Kavelaars A, Ballieux RE, Heijnen CJ. Beta-endorphin production by lymphocytes. Int J Neurosci 1990; 51(3-4):173-175.
54. Kavelaars A, Berkenbosch F, Croiset G et al. Induction of beta-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 1990; 126(2):759-764.
55. Woloski BM, Smith EM, Meyer III WJ et al. Corticotropin-releasing activity of monokines. Science 1985; 230(4729):1035-1037.
56. Fagarasan MO, Axelrod J. Interleukin-1 amplifies the action of pituitary secretagogues via protein kinases. Int J Neurosci 1990; 51(3-4):311-313.
57. Sanders VM, Baker RA, Ramer-Quinn DS et al. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 1997; 158(9):4200-4210.
58. Kavelaars A, Ballieux RE, Heijnen CJ. In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin. Endocrinology 1990; 126(6):3028-3032.
59. Kavelaars A, Ballieux RE, Heijnen CJ. Two different signalling pathways for the induction of immunoreactive beta-endorphin secretion by human peripheral blood mononuclear cells. Endocrinology 1991; 128(2):765-770.
60. Zurawski G, Benedik M, Kamb BJ et al. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 1986; 232(4751):772-775.
61. Martin J, Prystowsky MB, Angeletti RH. Preproenkephalin mRNA in T-cells, macrophages, and mast cells. J Neurosci Res 1987; 18(1):82-87.
62. Rosen H, Behar O, Abramsky O, Ovadia H. Regulated expression of proenkephalin A in normal lymphocytes. J Immunol 1989; 143(11):3703-3707.
63. Linner KM, Beyer HS, Sharp BM. Induction of the messenger ribonucleic acid for proenkephalin A in cultured murine CD4-positive thymocytes. Endocrinology 1991; 128(2):717-724.
64. Linner KM, Nicol SE, Sharp BM. IL-1 beta modulates the concanavalin-A-induced expression of proenkephalin A mRNA in murine thymocytes. J Pharmacol Exp Ther 1993; 267(3):1566-1572.
65. Linner KM, Quist HE, Sharp BM. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J Immunol 1995; 154(10):5049-5060.
66. Linner KM, Quist HE, Sharp BM. Expression and function of proenkephalin A messenger ribonucleic acid in murine fetal thymocytes. Endocrinology 1996; 137(3):857-863.
67. Behar O, Ovadia H, Polakiewicz RD et al. Lipopolysaccharide induces proenkephalin gene expression in rat lymph nodes and adrenal glands. Endocrinology 1994; 134(1):475-481.
68. Ovadia H, Magenheim Y, Behar O et al. Molecular characterization of immune derived proenkephalin mRNA and the involvement of the adrenergic system in its expression in rat lymphoid cells. J Neuroimmunol 1996; 68(1-2):77-83.
69. Przewlocki R, Hassan AH, Lason W et al. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 1992; 48(2):491-500.
70. Fulford AJ, Harbuz MS, Jessop DS. Antisense inhibition of pro-opiomelanocortin and proenkephalin A messenger RNA translation alters rat immune cell function in vitro. J Neuroimmunol 2000; 106(1-2):6-13.
71. Pfluger KH, Gramse M, Gropp C et al. Ectopic ACTH production with autoantibody formation in a patient with acute myeloblastic leukemia. N Engl J Med 1981; 305(27):1632-1636.
72. Bayle JD, Guellati M, Ibos F et al. Brucella abortus antigen stimulates the pituitary-adrenal axis through the extrapituitary B-lymphoid system. Prog Neuroendocrinimmunol 1991; 4:99-105.
73. DuPont AG, Somers G, Van Steirteghem AC et al. Ectopic adrenocorticotropin production: disappearance after removal of inflammatory tissue. J Clin Endocrinol Metab 1984; 58(4):654-658.
74. Dunn AJ. The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res Bull 1992; 29(6):807-812.
75. Faden AI, Holaday JW. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat. J Pharmacol Exp Ther 1980; 212(3):441-447.
76. Bohs CT, Fish JC, Miller TH et al. Pulmonary vascular response to endotoxin in normal and lymphocyte depleted sheep. Circ Shock 1979; 6(1):13-21.
77. Harbour DV, Smith EM, Blalock JE. Novel processing pathway for proopiomelanocortin in lymphocytes: endotoxin induction of a new prohormone-cleaving enzyme. J Neurosci Res 1987; 18(1):95-101.
78. Harbour DV, Smith EM, Blalock JE. Splenic lymphocyte production of an endorphin during endotoxic shock. Brain Behav Immun 1987; 1(2):123-133.
79. Harbour DV, Galin FS, Hughes TK et al. Role of leukocyte-derived pro-opiomelanocortin peptides in endotoxic shock. Circ Shock 1991; 35(3):181-191.
80. Machelska H, Stein C. Pain control by immune-derived opioids. Clin Exp Pharmacol Physiol 2000; 27(7):533-536.
81. Stein C, Hassan AH, Przewlocki R et al. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990; 87(15):5935-5939.
82. Stein C, Gramsch C, Hassan AH et al. Local opioid receptors mediating antinociception in inflammation: endogenous ligands. Prog Clin Biol Res 1990; 328:425-427.
83. Stein C, Hassan AH, Lehrberger K et al. Local analgesic effect of endogenous opioid peptides. Lancet 1993; 342(8867):321-324.
84. Czlonkowski A, Stein C, Herz A. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur J Pharmacol 1993; 242(3):229-235.
85. Mousa SA, Schafer M, Mitchell WM et al. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol 1996; 311(2-3):221-231.
86. Schafer M, Carter L, Stein C. Interleukin-1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994; 91(10):4219-4223.
87. Donnerer J, Schuligoi R, Stein C et al. Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor. Regul Pept 1993; 46(1-2):150-154.
88. Hassan AH, Pzewlocki R, Herz A et al. Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosci Lett 1992; 140(1):85-88.
89. Mousa SA, Machelska H, Schafer M et al. Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. J Neuroimmunol 2000; 108(1-2):160-170.
90. Schafer M, Zhou L, Stein C. Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue. Neuroscience 1998; 82(2):603-611.
91. Stephanou A, Sarlis NJ, Knight RA et al. Response of pituitary and spleen pro-opiomelanocortin mRNA, and spleen and thymus interleukin-1 beta mRNA to adjuvant arthritis in the rat. J Neuroimmunol 1992; 37(1-2):59-63.
92. Jessop DS, Lightman SL, Chowdrey HS. Effects of a chronic inflammatory stress on levels of pro-opiomelanocortin-derived peptides in the rat spleen and thymus. J Neuroimmunol 1994; 49(1-2):197-203.
93. Jessop DS, Renshaw D, Lightman SL et al. Changes in ACTH and beta-endorphin immunoreactivity in immune tissues during a chronic inflammatory stress are not correlated with changes in corticotropin-releasing hormone and arginine vasopressin. J Neuroimmunol 1995; 60(1-2):29-35.
94. Jessop DS, Harbuz MS, Snelson CL et al. An antisense oligodeoxynucleotide complementary to corticotropin- releasing hormone mRNA inhibits rat splenocyte proliferation in vitro. J Neuroimmunol 1997; 75(1-2):135-140.
95. Panerai AE, Manfredi B, Sacerdote P. Beta-endorphin concentrations in resting peripheral mononuclear cells and after treatment with PHA or serotoninergic drugs in human aging, Alzheimer's disease, and Down's syndrome. Ann N Y Acad Sci 1992; 663:311-318.
96. Gironi M, Martinelli V, Brambilla E et al. Beta-endorphin concentrations in peripheral blood mononuclear cells of patients with multiple sclerosis: effects of treatment with interferon beta. Arch Neurol 2000; 57(8):1178-1181.
97. Wiedermann CJ, Sacerdote P, Mur E et al. Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with rheumatic diseases. Clin Exp Immunol 1992; 87(2):178-182.
98. Wiedermann CJ, Sacerdote P, Propst A et al. Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease. Brain Behav Immun 1994; 8(3):261-269.
99. Buratti T, Schratzberger P, Dunzendorfer S et al. Decreased levels of beta-endorphin in circulating mononucleas leukocytes from patients with acute myocardial infarction. Cardiology 1998; 90(1):43-47.
100. Panerai AE, Radulovic J, Monastra G et al. Beta-endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: a possible relationship between tumor necrosis factor alpha and opioids in the disease. J Neuroimmunol 1994; 51(2):169-176.
101. Brambilla F, Brunetta M, Draisci A et al. T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders: 11. Bulimia nervosa. Psychiatry Research 1995; 59(1-2):51-56.
102. Brambilla F, Maggioni M, Panerai AE et al. Beta-endorphin concentration in peripheral blood mononuclear cells of elderly depressed patients - effects of phosphatidylserine therapy. Neuropsychobiology 1996; 34(1):18-21.
103. Panza G, Monzani E, Sacerdote P et al. Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients. Acta Psychiatrica Scandinavica 1992; 85(3):207-210.
104. Brambilla F, Guareschi-Cazzullo A, Tacchini C et al. Beta-endorphin and cholecystokinin 8 concentrations in peripheral blood mononuclear cells of autistic children. Neuropsychobiology 1997; 35(1): 1-4.
105. Sacerdote P, Bianchi M, Manfredi B et al. Intracerebroventriculas interleukin-1 alpha increases immunocyte beta-endorphin concentrations in the rat: involvement of corticotropin-releasing hormone, catecholamines, and serotonin. Endocrinology 1994; 135(4):1346-1352.
106. Sacerdote P, Manfredi B, Bianchi M et al. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immun 1994; 8(3):251-260.
107. Panerai AE, Sacerdote P, Bianchi M et al. Intermittent but not continuous inescapable footshock stress and intracerebroventriculat interleukin-1 similarly affect immune responses and immunocyte beta-endorphin concentrations in the rat. Int J Clin Pharmacol Res 1997; 17(2-3):115-116.
108. Sacerdote P, Denis-Donini S, Paglia P et al. Cloned microglial cells but not macrophages synthesize beta- endorphin in response to CRH activation. GLIA 1993; 9(4):305-310.
109. Stephanou A, Jessop DS, Knight RA et al. Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 1990; 4(1):67-73.
110. Smith EM. Hormonal activities of cytokines. Chem Immunol 1997; 69:185-202.
111. Smith EM, Cadet P, Stefano GB et al. IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 1999; 100(1-2):140-148.
112. Opp MR, Rady PL, Hughes TKJ et al. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats. Am J Physiol 1996; 270(5 Pt 2):R963-R970.
113. Halford WP, Gebhardt BM, Carr DJ. Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J Neuroimmunol 1995; 59(1-2):91-101.
114. Pampusch MS, Serie JR, Osinski MA et al. Expression of nociceptin/OFQ receptor and prepro-nociceptin/OFQ in lymphoid tissues. Peptides, 2000; 21(12):1865-1870.
115. Duvaux-Miret O, Stefano GB, Smith EM et al. Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides. Proc Natl Acad Sci USA 1992; 89(2):778-781.
116. Chuang TK, Killam KF, Jr., Chuang LF et al. Mu opioid receptor gene expression in immune cells. Biochem Biophys Res Commun 1995; 216(3):922-930.
117. Sedqi M, Roy S, Ramakrishnan S et al. Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun 1995; 209(2):563-574.
118. Chuang LF, Chuang TK, Killam KF, Jr. et al. Delta opioid receptor gene expression in lymphocytes. Biochem Biophys Res Commun 1994; 202(3):1291-1299.
119. Chuang LF, Chuang TK, Killam KF, Jr. et al. Expression of kappa opioid receptors in human and monkey lymphocytes. Biochem Biophys Res Commun 1995; 209(3):1003-1010.